Cargando…
Clinical implications of cardiovascular outcome trials in type 2 diabetes
Cardiovascular disease (CVD) is the main reason for premature death in patients with type 2 diabetes. Hyperglycemia, the hallmark of diabetes, has long been considered the link between diabetes and CVD, and many trials focused on preventing CVD manifestations by means of tight glucose control. Howev...
Autores principales: | Mellbin, L. G., Wang, A., Rydén, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507479/ https://www.ncbi.nlm.nih.gov/pubmed/30805659 http://dx.doi.org/10.1007/s00059-019-4789-4 |
Ejemplares similares
-
Glucose-lowering therapy in type 2 diabetes: New hope after the EMPA-REG outcome trial
por: Schernthaner, G., et al.
Publicado: (2016) -
Comfrey root: from tradition to modern clinical trials
por: Staiger, Christiane
Publicado: (2012) -
Progress in Rett Syndrome: from discovery to clinical trials
por: Percy, Alan K.
Publicado: (2016) -
Outcomes research in non-specific low back pain: Knowledge transfer in clinical practice
por: Stamm, Tanja A., et al.
Publicado: (2019) -
Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia
por: Lackner, David, et al.
Publicado: (2022)